Evolution in the management of vestibular schwannoma: a single-center 15-year experience
European Archives of Oto-Rhino-Laryngology · 2023
DOI: 10.1007/s00405-023-08009-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2023. Verfasst von Youssef El Sayed Ahmad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otology, Otoneurology and Pediatric Otolaryngology, Pierre-Paul Riquet Hospital, Toulouse University hospital, Toulouse, France. Yousse…. Hauptthemen laut MEDLINE: Neuroma, Acoustic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To highlight the changes in the management of vestibular schwannoma (VS) since 2004 with a focus on small- to middle-size VS. METHODS: Retrospective analysis of the decisions made in skull base tumor board between 2004 and 2021. RESULTS: 1819 decisions were analyzed (average age 59.25, 54% females). Overall, 850 (47%) cases were allocated to a Wait and Scan (WS) approach, 416 (23%) received radiotherapy and 553 (30%) were treated surgically (MS). All stages considered WS increased from 39% before 2010 to 50% after 2010. Similarly, Stereotactic Radio Therapy (SRT) increased from 5 to 18%. MS decreased from 46 to 25%. It was more commonly proposed to younger patients and larger tumors, p < 0.001. For Koos stages 1, 2, and 3 there was a statistically significant increase in SRT, and a decrease in MS, p < 0.001. WS also increased for stages 1 and 2. However, such a trend was not observed for stage 3. MS remained the primary treatment modality for stage 4 tumors throughout the study period, p = 0.057. The significance of advanced age as a factor favoring SRT decreased over time. The opposite is true for serviceable hearing. There was also a decrease in the percentage of the justification "young age" in the MS category. CONCLUSION: The is a continuing trend towards non-surgical treatment. Small- to medium-sized VS witnessed an increase in both WS and SRT. There is only an increase in SRT for moderately large VS. Physicians are less and less considering young age as a factor favoring MS over SRT. There is a tendency towards favoring SRT when hearing is serviceable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otology, Otoneurology and Pediatric Otolaryngology, Pierre-Paul Riquet Hospital, Toulouse University hospital, Toulouse, France. Youssef-sa@live.com.
- Department of Otology, Otoneurology and Pediatric Otolaryngology, Pierre-Paul Riquet Hospital, Toulouse University hospital, Toulouse, France.
- Neuro-Surgery Department, CHU de Toulouse, Purpan, 31000, Toulouse, France.
- Radiotherapy Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
- Department of Neuroradiology, Purpan Hospital, Toulouse, France.
- Department of Neurology, Pierre-Paul Riquet/Purpan University Hospital, Toulouse, France.
Zitieren
APA
El Sayed Ahmad, Y., Gallois, Y., Sol, J. C., Boetto, S., Attal, J., Sabatier, J., Debs, R., Deguine, O., & Marx, M. (2023). Evolution in the management of vestibular schwannoma: a single-center 15-year experience. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-023-08009-6
Vancouver
El Sayed Ahmad Y, Gallois Y, Sol JC, Boetto S, Attal J, Sabatier J, et al. Evolution in the management of vestibular schwannoma: a single-center 15-year experience. European Archives of Oto-Rhino-Laryngology. 2023. doi:10.1007/s00405-023-08009-6
BibTeX
@article{ElSayedAhmad2023,
author = {El Sayed Ahmad, Youssef and Gallois, Yohan and Sol, Jean Christophe and Boetto, Sergio and Attal, Justine and Sabatier, Jean and Debs, Rachel and Deguine, Olivier and Marx, Mathieu},
title = {Evolution in the management of vestibular schwannoma: a single-center 15-year experience},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2023},
doi = {10.1007/s00405-023-08009-6}
}
EUVIMED